 | |
| Discipline | Neurology |
|---|---|
| Language | English |
| Edited by | Maral Mouradian |
| Publication details | |
| History | 2004-present |
| Publisher | Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics |
| Frequency | Quarterly |
| 7.620 (2020) | |
| Standard abbreviations | |
| ISO 4 | Neurotherapeutics |
| Indexing | |
| ISSN | 1933-7213 (print) 1878-7479 (web) |
| LCCN | 2006215616 |
| OCLC no. | 82448136 |
| Links | |
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
Abstracting and indexing
The journal is abstracted and indexed in:
- Science Citation Index Expanded
- Index Medicus/PubMed/MEDLINE
- Scopus
- PsycINFO
- EMBASE
- Chemical Abstracts Service
- EBSCO databases
- Academic OneFile
- Current Contents/Life Sciences
- Current Contents/Clinical Medicine
According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620.[1]
References
- ↑ "Neurotherapeutics". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2020.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.